
Metabolic & Weight
5-Amino-1MQ
NNMT Inhibitor
Price
$88

Metabolic & Weight Research
GIP/GLP-1/Glucagon Triple Agonist
A triple-agonist peptide (formerly listed as retatrutide) with activity at the GIP, GLP-1 and glucagon receptors, studied in metabolic and energy-balance research models.
GLP-3 (formerly listed as retatrutide) adds a third arm to the incretin-agonist design: a single molecule with activity at the GIP, GLP-1 and glucagon receptors. The glucagon component is what separates it from dual agonists in energy-balance work, and it is typically characterized against both single- and dual-agonist references to isolate that contribution. Supplied lyophilized in 10, 20 and 30 mg presentations for comparative receptor studies.
Research context
Strength / format
10 mg selected. $148. Batch RV-GL3-2610.
Batch GLP3-10-2026-01 · Tested 2026-07-28
99.4% measured. two analytes tested, all within specification.
Analyzed by JanoShield Analytical.
$148
$14.80 per mg
Dispatched within 24 hours, Monday to Friday, in discreet, unmarked packaging. Free shipping over $200 — $52 away.
COA match guarantee — if the vial you receive does not match the , we replace or refund it. Unopened vials in original packaging can be returned within 14 days of delivery.
A batch that misses specification is not listed and is not shipped. We publish every result we commission, including the ones that send a batch back.
Chromatogram and mass-spectrometry data for batch GLP3-10-2026-01 are available on request.
For Research Use Only — Not for Human Consumption.
Specifications
Every lot in this catalog clears the same sequence. The dates below belong to batch GLP3-10-2026-01 — the lot currently being picked for this product.
Lyophilized to specification and sealed under controlled conditions, one lot at a time.
Lot GLP3-10-2026-01
RP-HPLC with UV detection at 220 nm — the peptide-bond absorbance, so every residue in the sequence contributes to the signal. Release specification ≥ 98.0%.
Result 99.4%
LC-MS (ESI) measures the molecular mass of the eluting species against the theoretical mass of the intended sequence. A lot can be pure and still be the wrong peptide; running both methods closes that gap.
Confirmed
Purity, identity, appearance, peptide content, water, acetate and endotoxins all within specification. Released for sale.
Tested 2026-07-28
It is not listed and it is not shipped. We publish every result we commission, including the ones that send a batch back. A batch earns a product page only after identity and purity have both passed.
Chromatographic purity and peptide content answer different questions. Purity is the share of peptide-related material that is the target sequence. Peptide content is how much of the vial's mass is peptide at all, the remainder being acetate counterion and residual water — a normal lyophilized acetate salt, not a discrepancy.
Analysis is performed by JanoShield Analytical, an independent laboratory with no commercial interest in the result.
For Research Use Only — Not for Human Consumption.
GLP-3 (formerly listed as retatrutide) adds a third arm to the incretin-agonist design: a single molecule with activity at the GIP, GLP-1 and glucagon receptors. The glucagon component is what separates it from dual agonists in energy-balance work, and it is typically characterized against both single- and dual-agonist references to isolate that contribution. Supplied lyophilized in 10, 20 and 30 mg presentations for comparative receptor studies.
Every lot is assayed by third-party hplc and mass spectrometry, per batch: RP-HPLC at 220 nm establishes chromatographic purity against a 99% release specification, and LC-MS confirms molecular identity against the reference mass. The batch currently shipping is RV-GL3-2610, and its full certificate — including methods, specifications, measured results, and the testing laboratory — is published at https://rovapeptides.com/coas/RV-GL3-2610.
Lyophilized powder, sealed vial. Store lyophilized at -20 °C, protected from light and moisture. Refrigerate after reconstitution. Reconstitute with bacteriostatic water in a controlled laboratory setting; swirl gently rather than shaking to preserve peptide structure.
GLP-3 is supplied in 10 mg, 20 mg and 30 mg. Each presentation is filled from a tested lot and ships with its own batch number, so the certificate you retrieve always corresponds to the vial in your hand.
No. GLP-3 is supplied strictly for laboratory and in-vitro research use. It is not intended for human or veterinary consumption, diagnostic use, or therapeutic use, and RovaPeptides provides no dosing, protocol, or usage guidance.
Related Research Products